| Michael J Choban, MD | |
|
3700 Kolbe Rd, Lorain, OH 44053-1611 | |
| (440) 323-8515 | |
| (440) 323-7900 |
| Full Name | Michael J Choban |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 38 Years |
| Location | 3700 Kolbe Rd, Lorain, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841291341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35054161 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Regional Medical Center | Lorain, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Elyria Anesthesia Incorporated | 7214902170 | 45 |
News Archive
Highlights of today's Scientific Program of the 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting include: John T. Flynn, MD, Columbia University School of Medicine, discussing the ever-tougher challenges Eye M.D.s face in caring for the vision of the tiniest premature babies; and a report by Bradford W. Lee, MD, Stanford University School of Medicine, on barriers to glaucoma follow-up as perceived by patients in an urban, culturally diverse clinic.
Cancer is a leading cause of death in aging populations. Despite decades of research, cancer treatments are still inefficient and have unacceptable side effects that continue to prompt an urgent need for new approaches to prevention and treatment.
Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.
Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.
A selection of health policy news from Oregon, Texas, Maryland, California, Georgia and Wisconsin.
› Verified 6 days ago
| Entity Name | Elyria Anesthesia Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710922463 PECOS PAC ID: 7214902170 Enrollment ID: O20040901001554 |
News Archive
Highlights of today's Scientific Program of the 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting include: John T. Flynn, MD, Columbia University School of Medicine, discussing the ever-tougher challenges Eye M.D.s face in caring for the vision of the tiniest premature babies; and a report by Bradford W. Lee, MD, Stanford University School of Medicine, on barriers to glaucoma follow-up as perceived by patients in an urban, culturally diverse clinic.
Cancer is a leading cause of death in aging populations. Despite decades of research, cancer treatments are still inefficient and have unacceptable side effects that continue to prompt an urgent need for new approaches to prevention and treatment.
Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.
Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.
A selection of health policy news from Oregon, Texas, Maryland, California, Georgia and Wisconsin.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael J Choban, MD 860 E Broad Street Ste I, Elyria, OH 44035-6542 Ph: (440) 323-8515 | Michael J Choban, MD 3700 Kolbe Rd, Lorain, OH 44053-1611 Ph: (440) 323-8515 |
News Archive
Highlights of today's Scientific Program of the 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting include: John T. Flynn, MD, Columbia University School of Medicine, discussing the ever-tougher challenges Eye M.D.s face in caring for the vision of the tiniest premature babies; and a report by Bradford W. Lee, MD, Stanford University School of Medicine, on barriers to glaucoma follow-up as perceived by patients in an urban, culturally diverse clinic.
Cancer is a leading cause of death in aging populations. Despite decades of research, cancer treatments are still inefficient and have unacceptable side effects that continue to prompt an urgent need for new approaches to prevention and treatment.
Penn Medicine will conduct the Northeast's first clinical trial of uterine transplants, to provide women with Uterine Factor Infertility (UFI) - an irreversible form of female infertility that affects as many as 5 percent of women worldwide and 50,000 women in the United States - with a new path to parenthood.
Sweden's MPA has today granted the first regulatory approval in the world for FOSRENOL (lanthanum carbonate), a non-calcium, non-aluminium phosphate binding medicine developed to control phosphate levels in renal dialysis patients. Sweden will now become the Reference Member State in the EU Mutual Recognition Procedure for FOSRENOL, and this is the first step in securing marketing approval throughout Europe. A submission has also been made by Shire to gain marketing approval for FOSRENOL in the United States.
A selection of health policy news from Oregon, Texas, Maryland, California, Georgia and Wisconsin.
› Verified 6 days ago
Dr. Nicholas Niemiec, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Mercy Health Lorain Hospital, 3700 Kolbe Road, Lorain, OH 44053 Phone: 440-323-8515 | |
Sameh R Yonan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4804 Leavitt Rd, Lorain, OH 44053 Phone: 440-989-2066 Fax: 440-989-1153 | |
Dr. James Regis Coleman Iii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6125 S Broadway, Lorain, OH 44053 Phone: 440-233-8181 Fax: 440-233-8182 | |
Dr. Victoria Gilbride, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3700 Kolbe Rd, Lorain, OH 44053 Phone: 440-960-4000 | |
Todd W. Sleeper, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6125 S Broadway, Lorain, OH 44053 Phone: 440-233-8181 Fax: 440-233-8182 | |
Dr. Maamun D Darwich, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6125 S Broadway, Lorain, OH 44053 Phone: 440-233-8181 Fax: 440-233-8182 | |
Jesus Jose Castruita Jr., MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 6125 S Broadway, Lorain, OH 44053 Phone: 440-233-8181 Fax: 440-233-8182 |